State Street Exits Relay Therapeutics Stake as of Dec 31, 2023
Ticker: RLAY · Form: SC 13G/A · Filed: Jan 23, 2024 · CIK: 1812364
| Field | Detail |
|---|---|
| Company | Relay Therapeutics, Inc. (RLAY) |
| Form Type | SC 13G/A |
| Filed Date | Jan 23, 2024 |
| Risk Level | medium |
| Sentiment | bearish |
Complexity: simple
Sentiment: bearish
Topics: institutional-ownership, exit-filing, share-sale
TL;DR
**State Street just dumped its Relay Therapeutics shares, watch out!**
AI Summary
State Street Corporation, a major financial institution, filed an amended Schedule 13G/A on January 23, 2024, indicating its ownership in Relay Therapeutics, Inc. as of December 31, 2023. This filing is an 'exit filing,' meaning State Street Corporation no longer holds a reportable ownership stake (above 5%) in Relay Therapeutics. This matters to investors because a large institutional investor has significantly reduced or eliminated its position, which could signal a change in their outlook on the company's future prospects.
Why It Matters
This 'exit filing' signals that a major institutional investor, State Street Corporation, has sold off its significant stake in Relay Therapeutics, which could be interpreted negatively by the market.
Risk Assessment
Risk Level: medium — The exit of a large institutional investor like State Street Corporation could indicate a loss of confidence and potentially lead to downward pressure on the stock price.
Analyst Insight
A smart investor would monitor Relay Therapeutics' stock for potential downward pressure and research if other institutional investors are also reducing their stakes, while also looking for any new positive catalysts that could offset this news.
Key Players & Entities
- State Street Corporation (company) — the reporting person filing the SC 13G/A, indicating an exit from its position
- Relay Therapeutics, Inc. (company) — the subject company in which State Street Corporation previously held a stake
- December 31, 2023 (date) — the date of the event which required the filing of this statement, indicating when the ownership change occurred
- January 23, 2024 (date) — the date the SC 13G/A filing was made public
Forward-Looking Statements
- Relay Therapeutics' stock price may experience short-term volatility. (Relay Therapeutics, Inc.) — medium confidence, target: Q1 2024
- Other institutional investors might re-evaluate their positions in Relay Therapeutics. (Relay Therapeutics, Inc.) — medium confidence, target: Q2 2024
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as indicated by 'FORM TYPE: SC 13G/A' and 'SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934'.
Who is the reporting person in this filing?
The reporting person is STATE STREET CORPORATION, as stated under '1. NAME OF REPORTING PERSON: STATE STREET CORPORATION'.
What is the subject company of this filing?
The subject company is Relay Therapeutics, Inc., identified as 'Relay Therapeutics, Inc.' under 'SUBJECT COMPANY: COMPANY DATA:' and 'RELAY THERAPEUTICS INC (NAME OF ISSUER)'.
What is the significance of the 'EXIT FILING' designation?
The 'EXIT FILING' designation indicates that the reporting person, State Street Corporation, no longer holds a reportable ownership stake (typically above 5%) in Relay Therapeutics, Inc., as of the date of the event.
What was the date of the event that triggered this filing?
The date of the event which required the filing of this statement was 12/31/2023, as specified under 'DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT'.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 23, 2024 regarding Relay Therapeutics, Inc. (RLAY).